In the SURMOUNT-1 obesity trial, treatment discontinuation due to adverse events rose from 2.6% on placebo to 4.3% at 5 mg, 7.1% at 10 mg, and 6.2% at 15 mg
Our dedicated medical team takes the time to educate and guide you, ensuring you understand the difference between naturally occurring GLP-1 and pharmaceutical interventions designed to enhance your health
Needle type: 2931 gauge insulin syringe Depth: 1/4 to 1/2 inch Best for: Muscle soreness, systemic healing, gut support For general recovery or post-cycle support, SubQ is the most convenient and well-tolerated option
There are 12 references cited in this article, which can be found at the bottom of the page
Mounjaro goes a step further, as it's a dual GIP/GLP-1 receptor agonist, meaning it acts on the GIP hormone as well